Tisdag 27 Oktober | 09:04:04 Europe / Stockholm
Est. tid*
2027-02-09 08:00 Bokslutskommuniké 2026
2026-10-27 08:00 Kvartalsrapport 2026-Q3
2026-07-14 - Kvartalsrapport 2026-Q2
2026-05-07 - X-dag ordinarie utdelning DEDI 1.75 SEK
2026-05-06 - Årsstämma
2026-04-28 - Kvartalsrapport 2026-Q1
2026-02-06 - Bokslutskommuniké 2025
2025-10-23 - Kvartalsrapport 2025-Q3
2025-07-11 - Kvartalsrapport 2025-Q2
2025-04-29 - X-dag ordinarie utdelning DEDI 2.50 SEK
2025-04-25 - Årsstämma
2025-04-24 - Kvartalsrapport 2025-Q1
2025-02-07 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-07-12 - Kvartalsrapport 2024-Q2
2024-04-26 - X-dag ordinarie utdelning DEDI 6.50 SEK
2024-04-25 - Årsstämma
2024-04-25 - Kvartalsrapport 2024-Q1
2024-02-09 - Bokslutskommuniké 2023
2023-10-20 - Kvartalsrapport 2023-Q3
2023-07-14 - Kvartalsrapport 2023-Q2
2023-04-21 - X-dag ordinarie utdelning DEDI 6.00 SEK
2023-04-20 - Årsstämma
2023-04-20 - Kvartalsrapport 2023-Q1
2023-02-17 - Bokslutskommuniké 2022
2022-10-21 - Kvartalsrapport 2022-Q3
2022-07-15 - Kvartalsrapport 2022-Q2
2022-04-22 - X-dag ordinarie utdelning DEDI 4.00 SEK
2022-04-21 - Årsstämma
2022-04-21 - Kvartalsrapport 2022-Q1
2022-02-10 - Bokslutskommuniké 2021
2021-10-21 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-04-23 - X-dag ordinarie utdelning DEDI 2.50 SEK
2021-04-22 - Årsstämma
2021-04-22 - Kvartalsrapport 2021-Q1
2021-02-09 - Bokslutskommuniké 2020
2020-10-23 - Kvartalsrapport 2020-Q3
2020-07-15 - Kvartalsrapport 2020-Q2
2020-04-24 - X-dag ordinarie utdelning DEDI 0.00 SEK
2020-04-23 - Årsstämma
2020-04-23 - Kvartalsrapport 2020-Q1
2020-02-07 - Bokslutskommuniké 2019
2019-10-24 - Kvartalsrapport 2019-Q3
2019-07-17 - Kvartalsrapport 2019-Q2
2019-04-26 - X-dag ordinarie utdelning DEDI 4.00 SEK
2019-04-25 - Årsstämma
2019-04-25 - Kvartalsrapport 2019-Q1
2019-02-07 - Bokslutskommuniké 2018
2018-10-24 - Kvartalsrapport 2018-Q3
2018-07-13 - Kvartalsrapport 2018-Q2
2018-04-25 - X-dag ordinarie utdelning DEDI 5.00 SEK
2018-04-24 - Årsstämma
2018-04-24 - Kvartalsrapport 2018-Q1
2018-02-07 - Bokslutskommuniké 2017
2017-10-24 - Kvartalsrapport 2017-Q3
2017-07-14 - Kvartalsrapport 2017-Q2
2017-04-25 - X-dag ordinarie utdelning DEDI 4.50 SEK
2017-04-25 - X-dag bonusutdelning DEDI 3.5
2017-04-24 - Årsstämma
2017-04-24 - Kvartalsrapport 2017-Q1
2017-02-07 - Bokslutskommuniké 2016
2016-10-25 - Kvartalsrapport 2016-Q3
2016-07-14 - Kvartalsrapport 2016-Q2
2016-04-26 - X-dag bonusutdelning DEDI 2.3
2016-04-26 - X-dag ordinarie utdelning DEDI 1.70 SEK
2016-04-25 - Årsstämma
2016-04-25 - Kvartalsrapport 2016-Q1
2016-02-05 - Bokslutskommuniké 2015
2015-10-23 - Kvartalsrapport 2015-Q3
2015-07-16 - Kvartalsrapport 2015-Q2
2015-04-23 - X-dag ordinarie utdelning DEDI 2.40 SEK
2015-04-22 - Årsstämma
2015-04-22 - Kvartalsrapport 2015-Q1
2015-02-05 - Bokslutskommuniké 2014
2014-10-24 - Kvartalsrapport 2014-Q3
2014-07-18 - Kvartalsrapport 2014-Q2
2014-04-23 - X-dag ordinarie utdelning DEDI 1.10 SEK
2014-04-22 - Årsstämma
2014-04-22 - Kvartalsrapport 2014-Q1
2014-02-06 - Bokslutskommuniké 2013
2013-10-25 - Kvartalsrapport 2013-Q3
2013-07-19 - Kvartalsrapport 2013-Q2
2013-04-24 - X-dag ordinarie utdelning DEDI 1.40 SEK
2013-04-23 - Årsstämma
2013-04-23 - Kvartalsrapport 2013-Q1
2013-02-07 - Bokslutskommuniké 2012
2012-10-25 - Kvartalsrapport 2012-Q3
2012-07-26 - Kvartalsrapport 2012-Q2
2012-04-25 - X-dag ordinarie utdelning DEDI 1.00 SEK
2012-04-24 - Årsstämma
2012-04-24 - Kvartalsrapport 2012-Q1
2012-02-08 - Bokslutskommuniké 2011
2011-11-29 - 15-7 2011
2011-10-27 - Kvartalsrapport 2011-Q3
2011-09-22 - Kapitalmarknadsdag 2011
2011-07-28 - Kvartalsrapport 2011-Q2
2011-04-26 - Kvartalsrapport 2011-Q1
LandSverige
ListaSmall Cap Stockholm
SektorTjänster
IndustriBemanning & Rekrytering
Dedicare Group är verksamt inom bemannings- och konsultbranschen och fokuserar på att tillhandahålla personal och konsulter till sjukvårdsinstitutioner och företag. Bolagets tjänster riktar sig till företag inom vård och omsorg som behöver stöd i rekrytering och projektledning. Verksamheten är främst koncentrerad till Sverige. Dedicare Group grundades år 1996 och har sitt huvudkontor i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Interim Report 1 January - 30 September 2026: Strong growth and improved profitability in the third quarter

2026-10-27 08:00:00

Third quarter 2026

· Net sales SEK 511.7 million (389.9)

· EBITA SEK 30.9 million (13.9), adjusted for non-recurring items SEK 34.4 million (13.9)

· EBITA margin 6.0 percent (3.6), adjusted for non-recurring items 6.7 percent (3.6)

· EBIT SEK 28.8 million (11.7)

· EBIT margin 5.6 percent (3.0)

· Profit after financial items SEK 25.3 million (11.7)

· Profit for the period SEK 19.5 million (9.6)

· Basic and diluted earnings per share SEK 2.01 (1.01)

 

The period January-September 2026

· Net sales SEK 1,261.9 million (1,093)

· EBITA SEK 59.7 million (37.4), adjusted for non-recurring items SEK 64.6 million (38.3)

· EBITA margin 4.7 percent (3.4), adjusted for non-recurring items 5.1 percent (3.5)

· EBIT SEK 53.3 million (30.5)

· EBIT margin 4.2 percent (2.8)

· Profit after financial items SEK 53.3 million (31.9)

· Profit for the period SEK 40.9 million (25.6)

· Basic and diluted earnings per share SEK 4.23 (2.68)

 

 

Performance measures

 

 

Chief Executive Officer's statement

 

Strong growth and improved profitability in the third quarter

 

Strong growth and significantly improved earnings characterised the third quarter. Progress was primarily driven by the acquired operations Hyldgaard & Larsen, Sustina and WeCare, which have expanded our proposition and consolidated our positioning in social care. Meanwhile, organic sales increased by 2.1 percent, while organic earnings were in line with the third quarter of 2025.

 

The group's net sales were SEK 511.7 million in the quarter, which is growth of 31.2 percent on the corresponding quarter of the previous year. EBITA was SEK 30.9 million (13.9), and our EBITA margin widened to 6.0 percent (3.6), the highest quarterly level since 2023. Most of the earnings gains were sourced from our acquired operations. Simultaneously, rationalisations executed and positive progress in parts of our staffing business contributed to a stable underlying earnings level. The healthcare staffing market is showing signs of more stability, even if demand does remain hesitant and competition is intense.

 

Our equity/assets ratio was 40.3 percent (51.4) at quarter-end. The group's financial position remains stable after the acquisitions completed in the quarter.

 

Norway, which represented 52 percent of consolidated sales in the quarter, reported sales of SEK 267.3 million, a 1.8 percent increase year on year. EBITA was SEK 12.0 million (14.8). Despite a demanding market, with price pressure and intense competition, this segment continued making a positive contribution to consolidated earnings.

 

We also started up Dedicare Omsorg (social care) in Norway in the quarter, focused on health and social care for young people in their own homes that's consistent with the group's ambition of expanding its social care proposition. 

 

We're continuing to experience faintly positive market progress in Sweden. Net sales were SEK 84.7 million, or growth of 12.2 percent year on year. EBITA improved to SEK 0.2 million (-0.7). Earnings were charged with SEK 1.8 million of restructuring expenses in the quarter. Underlying profit improved clearly on the corresponding quarter of the previous year. The downturn is mainly due to our staffing business, where continued demand restraint caused a lower activity level than in the corresponding quarter of the previous year. This lower activity also impacted organic earnings, although they remained positive.

 

Denmark reported sales of SEK 152.8 million, a 255.3 percent increase year on year. EBITA was SEK 23.7 million (1.5). Organic growth was -8.8 percent, while organic earnings were SEK 1.3 million (1.8), with the decrease mainly explained by the continued contracting limits on healthcare staff, which affected the staffing operation's sales and earnings.

 

Progress in Denmark reflects the Group's expansion in social care. With our acquisitions of Hyldgaard & Larsen and Sustina, consolidated since July, as well as WeCare, acquired in the fourth quarter of 2025, social care is playing a significant role alongside our core business in staffing.

 

These acquired operations have made a significant contribution to quarterly sales and earnings performance. The focus in Denmark is on developing our social care operations, while simultaneously prioritising the performance and profitability of our staffing operation.

 

We had a major reorganisation in the UK in the third quarter. The previous MD resigned on 1 September, and I've been serving as Interim MD in the UK since then. As part of this reorganisation, we centralised, integrating our resources to reduce complexity and create a more cost-efficient organisation.

 

Net sales in the UK were SEK 10.1 million (12.8), and EBITA was SEK -1.2 million (-0.5). Earnings were charged with restructuring expenses of SEK 1.4 million.

 

Overall, we reported strong performance in the third quarter. Our acquired operations made substantial contributions to the group's sales and earnings performance, while organic earnings were in line with the previous year. Market conditions remain challenging in several parts of our business, which is why we're still prioritising efforts to increase efficiency and underlying profitability.

 

In closing, I'd like to say a big thank-you to all our committed and skilled staff. Every day, Dedicare helps people across the Nordics and UK to get the health and social care they need, whether in metropolitan or rural environments.

 

This is a vital social mission that I'm truly proud of. The work our people do makes a real difference-to individuals and wider society.

 

Bård Kristiansen, CEO & Managing Director

 

 

This information is mandatory for Dedicare AB (publ) to publish pursuant to the EU Market Abuse Regulation (MAR). This information was submitted for publication through the agency of the below contact at 8 a.m. CET on 27 October 2026.

 

Bård Kristiansen, CEO & Managing Director, +47 97 08 88 83

Anette Sandsjö, CFO, +46 73 343 44 68

 

 

About Dedicare

At Dedicare, we're passionate about adding expertise to healthcare, life science and social work. We're driven by making a responsible and sustainable contribution to people's health, development and quality of life. Dedicare was founded in 1996 and is the Nordic region's largest recruitment and staffing provider. Since 2025, the group has also been active in social care. We have operations in Sweden, Norway, Denmark and in the UK. Dedicare is listed on Nasdaq Stockholm and had sales of SEK 1.5 billion in 2025. Each day, we have about 2,000 employees on assignment. We see Europe as our future market, and in time, our vision is to grow into one of Europe's leading recruitment and staffing providers in healthcare, life science and social work.

 

Read more about Dedicare at dedicaregroup.com